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Abstract
Our aim was to detect the presence of an alternative oxidase (AOX) in Candi-
da krusei clinical strains and its influence on fluconazole susceptibility and in
reactive oxygen species (ROS) production. Candida krusei clinical isolates were
tested to evaluate the presence of AOX. Debaromyces hansenii 2968 (AOX posi-
tive) and Saccharomyces cerevisiae BY4742 (AOX negative) were used as control
strains. Measurements of oxygen consumption were performed in the presence
of 1 mM KCN, an inhibitor of the classical respiratory chain, and 5 mM sali-
cylhydroxamic acid (SHAM). AOX expression was monitored by Western blot-
ting using an AOX monoclonal antibody. Interactions between fluconazole and
SHAM were performed using checkerboard assay. ROS production was evalu-
ated in the presence of SHAM plus fluconazole, H2O2, menadione, or plumba-
gin. AOX was present in all C. krusei tested. The combination of fluconazole
with SHAM resulted in an indifferent effect. In the presence of SHAM, the
treatment with ROS inductors or fluconazole increased ROS production, except
in the AOX-negative strain. An alternative respiratory pathway resistant to cya-
nide is described for the first time as a characteristic of C. krusei species. This
AOX is unrelated to fluconazole resistance; however, it protects C. krusei from
oxidative stress.
Introduction
Over the past few decades, authors have documented
increases in the rate of candidemia by non-albicans spe-
cies of Candida, such as Candida krusei, especially in crit-
ically ill and immunocompromised patients with
hematologic malignancies (Hachem et al., 2008).
Fluconazole is often used in the prophylaxis and treat-
ment of candidemia and is the first-line therapy for this
condition (Pappas et al., 2009). Among non-albicans spe-
cies, C. krusei is the only species that is predictably fluco-
nazole resistant (Oxman et al., 2010). Antifungal drug
tolerance can also be modulated by metabolic adaptability
mechanisms, including alterations in the respiratory mito-
chondrial pathway (Chamilos et al., 2006; Brun et al.,
2003). This fact had been previously assessed in C. glab-
rata, C. albicans, and C. parapsilosis regarding its
influence on fluconazole and caspofungin (Brun et al.,
2003; Chamilos et al., 2006; Yan et al., 2009).
In eukaryotic organisms, the energy necessary for
growth, development, reproduction, and stress response is
acquired through the ATP synthesized during mitochon-
drial respiration, where cytochrome c oxidase acts as a
terminal oxidase in the reception of electrons and con-
verting oxygen into water. Within the mitochondrial
respiratory chain, another route mediated by the alterna-
tive oxidase (AOX; a mitochondrial enzyme) can be
found in plants, in certain protozoa and fungi (Moore &
Siedow, 1991; Helmerhorst et al., 2002, 2005; Veiga et al.,
2003a, b). This AOX is insensitive to cytochrome pathway
inhibitors, such as antimicin A or cyanide, but is specifi-
cally inhibited by salicylhydroxamic acid (SHAM) and
confers a cyanide-resistant respiration through an alterna-
tive respiratory pathway (ARP) to such organisms (Moore
FEMS Yeast Res 12 (2012) 423–429 ª 2012 Federation of European Microbiological Societies
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& Siedow, 1991). The AOX is located on the matrix side
of the inner mitochondrial membrane and plays an
important role in susceptibility to azole antifungals in
C. albicans (Yan et al., 2009). The alternative respiratory
chain can be activated by stress situations like the pres-
ence of antifungals or oxidative inductors, thus leading to
drug tolerance and to the reduction in generation of
intracellular reactive oxygen species (ROS; Cannon et al.,
2007).
In an attempt to explain the contribution of mitochon-
drial respiration in the intrinsic fluconazole resistance dis-
played by C. krusei, we assessed the existence of an ARP
and its influence upon fluconazole resistance and toler-
ance to oxidative stress in C. krusei.
Materials and methods
Drugs and chemicals
Fluconazole was obtained from Pfizer (Groton, CT), and
stock solutions were prepared according to CLSI M27 A3
protocol and maintained at 70 °C until use (CLSI,
2008). Stock solutions of SHAM (200 mM; Sigma-
Aldrich, Germany) and potassium cyanide (KCN, 1 M;
Sigma) were prepared in DMSO (Sigma) and distilled
water, respectively. Hydrogen peroxide (H2O2; 30% v/v)
was obtained from Merck. Plumbagin and menadione
were obtained from Sigma, and stock solutions
(100 mM) were prepared in 95% ethanol. Dihydrorhod-
amine 123 (DHR123) was obtained from Molecular
Probes (Eugene, OR).
Strains and culture conditions
A total of 25 C. krusei (nine from respiratory secretions,
one from blood, 11 vaginal, three fecal, and the type
strain ATCC 6258 from the American Type Culture Col-
lection), previously identified using VITEK II system
(BioMe´rieux, Paris, France), all resistant to fluconazole
were used in this study. Candida albicans SC5314 strain
was used as positive control for the presence of AOX-spe-
cific protein. The strains were grown in Sabouraud dex-
trose broth (Difco) at 30 °C, in an orbital shaker at
150 r.p.m. until late exponential growth phase (OD640
1.5). Debaromyces hansenii IGC2968 (LGC Standards S.L.
U., Barcelona, Spain) was used as the positive control for
the presence of an ARP, assessed by oxygen consumption.
Saccharomyces cerevisiae BY4742 (EUROSCARF, Frank-
furt, Germany) was used throughout the study as the
negative control for the presence of the AOX assessed by
oxygen consumption, immunoblotting, and ROS produc-
tion. These control strains were grown in a mineral med-
ium with vitamins and 2% (w/v) glucose until stationary
growth phase (OD640 2.5 and 3, respectively; Veiga et al.,
2003a, b).
Alternative respiratory pathway
Late exponential phase cultures were centrifuged
(18 000 g) for 4 min at 4 °C and washed twice with cold
sterile water. An small amount (1.5 g wet weight) of pel-
let was resuspended in 100 mL of 50 mM phosphate-buf-
fered saline, pH 6.0 with 0.1% cicloheximide (Sigma, St.
Louis, MO), and 6 mL of suspension was incubated in a
small reactor at 28 °C. The O2 consumption was continu-
ously measured with a Clark-type electrode YSI model
5775 (YSI Incorporated, Yellow Springs, OH) after the
addition of 200 lL of 1.55 M glucose (Difco Laborato-
ries, Detroit, MI), 3.2 mM of KCN, and/or 3.2 mM of
SHAM (Sigma-Aldrich). The presence of an AOX was
considered whenever the oxygen consumption pattern
was resistant to KCN, but sensitive to SHAM.
Checkerboard microdilution assay
Checkerboard assays were performed with all C. krusei
strains, in the presence of fluconazole and SHAM, using
the protocol described in the Clinical Microbiology Pro-
cedures Handbook (Moody, 1991). The concentration
range used was 0.125–64 lg fluconazole mL1 and 0.6–
20 mM for SHAM. The minimal inhibitory concentra-
tions (MIC) of each compound were determined accord-
ing to CLSI M27 A3 and S3 protocol in RPMI 1640
(Sigma; CLSI, 2008). Fractional inhibitory concentration
of fluconazole (FICA) was calculated as the MIC of fluco-
nazole in combination/MIC of fluconazole alone, and
FICB is the MIC of SHAM in combination/MIC of
SHAM alone. The fractional inhibitory index (FIX) was
calculated as follows: FIX = FICA + FICB. The interpreta-
tion of FIX was as recommended:  0.5, synergistic
effect; > 0.5 to < 4.0, no interaction;  4.0, antagonistic
effect (Moody, 1991).
Assessment of intracellular ROS accumulation
Intracellular ROS accumulation was estimated to study
the influence of an AOX upon C. krusei oxidative stress
tolerance. After being washed and resuspended in PBS,
107 cells mL1 were treated with ROS inductors such as
H2O2 (0.4 mM), menadione (0.5 mM), and plumbagin
(0.003 mM) for 15, 30, and 60 min, at 35 °C under
150 r.p.m. Yeast cells were also treated with fluconazole
and voriconazole at MIC concentrations for 1 h. All the
treatments were repeated following the preincubation of
yeast cells with 3.2 mM of SHAM, an inhibitor of the
AOX, during 30 min. Control cells were treated with a
ª 2012 Federation of European Microbiological Societies FEMS Yeast Res 12 (2012) 423–429
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DMSO concentration similar to that used in cell samples
pretreated with SHAM. The cells were then collected by
centrifugation and resuspended in PBS. Free intracellular
ROS were detected with 15 lg dihydrorhodamine
123 mL1 (Molecular Probes; Almeida et al., 2007; Mesq-
uita et al., 2010). Cells were incubated during 90 min at
30 °C in the dark, washed in PBS, and 5 lL was placed
in a glass slide and overlapped with vectashield fluores-
cence mounting media (Vector Laboratories, Peterbor-
ough, UK). The stained suspensions were visualized
under epifluorescence microscopy (409; Olympus BX61).
In each condition, a minimum of 500 cells from three
different replicates were counted, and the percentage of
stained cells (cells displaying ROS) was determined.
Chronological life span
Overnight cultures of C. krusei strains were incubated in
YPD broth until stationary phase (day 0 of chronological
life span; Mesquita et al., 2010). Cultures were treated
without (control) and with 3.2 mM SHAM, 0.25 mM,
and 0.5 mM of menadione alone, and in combination
with 3.2 mM of SHAM. Survival was assessed daily by
counting colony-forming units (CFUs) from cultures
aliquots in YPD agar plates beginning at day 0 (when via-
bility was considered to be 100%).
Preparation of mitochondrial extracts
Mitochondrial extracts were isolated from S. cerevisiae,
Candida albicans SC5314, and C. krusei. Cells were grown
to stationary phase, harvested, and cell wall was digested
with zymolyase buffer [2 M sorbitol-D, phosphate buffer
1 M (pH 7.5), zymolyase 20 000 U, 125 mM b-mercap-
toethanol, 0.5 M EDTA] at 30°C for 1 h. Protoplasts
were disrupted with lysis buffer [sorbitol-D 0.5 M, Tris
20 mM, EDTA 1 mM, and 2.85 mM phenylmethanesul-
phonyl fluoride (PMSF)] using a Potter homogenizator.
Mitochondrial extracts were separated, washed by high-
speed centrifugation at 16 420 g for 15 min at 4°C (Beck-
man Coulter, JA-25.50 Rotor), and resuspended in sorbi-
tol buffer (0.5 sorbitol-D, 5 mM EDTA, 50 mM Tris).
Protein concentration was determined by Bradford
method (Kruger, 1994), and protein aliquots of mito-
chondrial extracts (40 lg) were stored at 20°C.
Immunoblotting
Mitochondrial protein extracts were resolved on a 12%
SDS gel and transferred to a nitrocellulose membrane.
The membrane was blocked with phosphate-buffered sal-
ine (TBS) with 0.1% Tween 20 (TBST) containing 5%
skim milk, followed by incubation with antibodies against
AOX proteins (1 : 100) of Sauromatum guttatum (Agri-
sera AB, Va¨nnas, Sweden) in TBST containing 1% skim
milk. After washing with TBS, the membranes were incu-
bated with the respective secondary antibody, HRP-conju-
gated anti-mouse IgG at a dilution of 1 : 5000, and
detected by enhanced chemiluminescence.
Statistical analysis
All experiments were performed in triplicate. Mean val-
ues were compared using Student’s t-test whenever indi-
cated. A P value < 0.05 was considered statistically
significant.
Results
Presence of a cyanide-resistant respiration
pathway in C. krusei
To investigate whether an ARP was present in clinical
isolates of C. krusei, measurements of O2 consumption
were performed in the presence of 3.2 mM of cyanide,
an inhibitor of the classical respiratory chain (by inhibit-
ing the cytochrome c oxidase complex), and SHAM, an
inhibitor of the ARP (by inhibiting the AOX). In C.
krusei strains, O2 consumption stopped only after the
addition of SHAM (Fig. 1a, representative example).
This observation was made for all the 24 C. krusei clini-
cal isolates, with ATCC 6258 type strain and with the
positive AOX control strain Debaromyces hansenii 2968
(Fig. 1b). In Saccharomyces cerevisiae BY4742, the nega-
tive AOX control strain, the oxygen consumption
stopped soon after the addition of cyanide (Fig. 1c).
The results indicate that C. krusei cells have a cyanide-
resistant respiration pathway promoted by the presence
of an AOX.
AOX expression
Mitochondrial preparations were immunoblotted with a
monoclonal antibody raised against S. guttatum AOX, but
also recognize C. albicans AOX (Huh & Kang, 1999). In
all C. krusei clinical isolates, mitochondrial AOX was
clearly detectable as well as in C. albicans SC5314 strain
(Fig. 2). Mitochondria isolated from the negative control
strain, S. cerevisiae BY4742, showed no reactivity with
AOX antiserum (Fig. 2).
Fluconazole–SHAM combination did not
influence fluconazole activity
To study the influence of the ARP upon fluconazole resis-
tance by C. krusei, we explored the in vitro combination
FEMS Yeast Res 12 (2012) 423–429 ª 2012 Federation of European Microbiological Societies
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of fluconazole and SHAM using the checkerboard meth-
odology. SHAM produced no impairment of antifungal
activity even at a concentration of 10 mM. The addition
of SHAM did not change MIC values for fluconazole,
resulting in an indifferent effect in all C. krusei isolates.
The presence of an alternative respiratory
pathway in C. krusei relates to reduced ROS
accumulation
To assess the influence of the ARP upon oxidative stress
response, we measured intracellular ROS accumulation
with and without SHAM, using DHR123. This fluoro-
chrome enters the yeast cell as a freely permeable dye,
which is converted to rhodamine 123 and subsequently
localized in the mitochondria. The conversion from the
nonfluorescent to the fluorescent molecule is entirely
dependent upon the presence of oxidation products. After
treatment with the ROS-inducing agents, H2O2, plumba-
gin, menadione, and with azoles, the percentage of
stained cells (cells with ROS accumulation) was calculated
and compared with values displayed by nontreated cells,
in the presence and absence of SHAM (3.2 mM). No sig-
nificant differences regarding ROS accumulation were
observed with the AOX-negative strain, S. cerevisiae
BY4742, in the presence or in the absence of SHAM
(Fig. 3). In contrast, after treatment with ROS-inducing
agents, C. krusei cells treated with SHAM produced sig-
nificantly (P < 0.001) more endogenous ROS than the
cells with the unblocked ARP (without SHAM; Fig. 3).
Significant differences in ROS production (P = 0.008)
were also accomplished with fluconazole (Fig. 3). All C.
krusei-tested strains displayed similar results.
Chronological life span decreased in C. krusei strains
incubated with menadione when compared with
untreated cultures (Fig. 4). The viability of C. krusei
strains reduced significantly after 3 days of incubating the
cultures with menadione plus SHAM (Fig. 4).
Discussion
Several authors have stressed the relevance of the mito-
chondrial respiration and its influence upon metabolic
behavior, stress environment adaptability, and antifungal
drug tolerance (Brun et al., 2003; Chamilos et al., 2006;
Yan et al., 2009; Li et al., 2011). A mitochondrial ARP
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Fig. 1. Effect of KCN and SHAM upon oxygen consumption by
Candida krusei clinical strain (representative example) (a),
Debaryomyces hansenii (AOX positive control strain) (b), and
Saccharomyces cerevisiae (AOX negative control strain) (c). Oxygen
consumption was measured with an oxygen electrode at 28 °C.
Where indicated (arrows), glucose (0.051 mM), KCN (3.2 mM), and
SHAM (3.2 mM) were added.
Fig. 2. Representative example of the presence of an AOX in
Candida krusei. Immunoblot analysis of AOX levels in 40 lg of
mitochondrial extracts of Saccharomyces cerevisiae (S.c.), Candida
albicans SC5314 (C.a.), and Candida krusei (C.k.).
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(cyanine-resistant) occurs in all higher plants, in many
fungi, and in some protozoa (Kirimura et al., 1999; John-
son et al., 2003). Such a pathway uses electrons from the
ubiquinol pool to reduce oxygen to water, bypassing the
complex III and the cytochrome oxidase complex, two
sites of energy conservation in the main respiratory chain.
An AOX, sensitive to SHAM and resistant to cyanide, is
responsible for this alternative pathway (McIntosh, 1994).
The cyanide-resistant respiration has been previously
described in C. albicans and C. parapsilosis (Helmerhorst
et al., 2002; Chamilos et al., 2006; Yan et al., 2009). In
this study, we described for the first time the presence of
an ARP mediated by an AOX in C. krusei.
The elucidation of the oxidative stress responses in
yeast has considerable clinical interest, as it is involved in
invasion and colonization of host tissues by yeast patho-
gens as well as during the defensive mechanisms triggered
by phagocytes. All aerobic organisms inevitably generate a
range of ROS, including superoxide anion, hydrogen per-
oxide, and hydroxyl radical during oxygen metabolism. If
not quickly and effectively eliminated from the cells, ROS
will trigger a large number of oxidative reactions in cellu-
lar systems that possibly lead to cell death (Raha &
Robinson, 2000). In the course of an in vivo infection,
the formation of ROS and other oxidants radicals by
phagocytes plays a crucial role in the intracellular destruc-
tion of the pathogen (Murphy, 1991). ROS attack almost
all essential cell components, including DNA, proteins,
and lipids (Moradas-Ferreira & Costa, 2000). In a recent
study, C. krusei appears to be resistant to ROS and to
possess a potent antioxidant system enabling deep sys-
temic infections (Abegg et al., 2010). We decided to eval-
uate the difference regarding oxidative stress response
before and after the blockade of the ARP. It has been pre-
viously described that in C. albicans, fluconazole is able
to induce the production and accumulation of ROS
(Kobayashi et al., 2002). In our study, we showed that
fluconazole induced a low percentage of ROS formation
by C. krusei cells. These results may suggest that the fun-
gistatic mechanism of this azole is not based upon ROS
formation. However, when the AOX was inhibited by
SHAM, an increase in the intracellular ROS levels was
evident. Attending to these facts, we can conclude that
AOX activity allows the yeast cells to reduce ROS accu-
mulation when challenged by antifungals like fluconazole,
leading to drug tolerance, like in C. albicans (Yan et al.,
2009). According to several authors, the AOX has a meta-
bolic and antioxidant role, and its presence may be con-
sidered a potential virulence attribute of pathogenic fungi
(Vanlerberghe et al., 2002; Missall et al., 2004; Yan et al.,
2009). The importance of AOX activity upon resistance
to oxidative stress was evident when the oxidative stress
inductors, H2O2, menadione, and plumbagin, were
assayed. After treatment with such compounds, ROS
accumulation was low. However, the scenario changed
significantly when the AOX activity was blocked by
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Fig. 3. Effect of fluconazole (FLC) and oxidative inductors
(menadione – Men; plumbagin – Plumb; hydrogen peroxide – H2O2)
upon intracellular ROS accumulation by a clinical Candida krusei (C.k.)
strain (representative example) and a negative control strain
Saccharomyces cerevisiae (S.c.), with or without the addition of
SHAM. ROS accumulation was calculated and expressed as the
percentage of DHR123-stained cells (*P < 0.05).
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Fig. 4. Chronological life span of a Candida krusei strain. Strains
were incubated without (control) and with 3.2 mM SHAM, 0.25 mM,
and 0.5 mM of menadione (Men) alone and in combination with
3.2 mM of SHAM. Survival was assessed daily by counting colony-
forming units (CFUs) from cultures aliquots in YPD agar plates
beginning at day 0 (when viability was considered to be 100%).
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SHAM. To confirm our hypothesis that the presence of
an ARP could protect C. krusei from oxidative stress, we
assessed ROS accumulation in the presence of fluconazole
and the other oxidative stress inductors by the negative
control strain, S. cerevisiae (AOX-). The results obtained
regarding ROS accumulation, in the presence or absence
of SHAM, were not significantly different. When testing
C. albicans AOX mutant strains, Yan and coworkers also
obtained no significant differences in the amount of ROS
generation (Yan et al., 2009). Regarding the chronological
life span assays, we could conclude that the decreased via-
bility of C. krusei strains in the presence of menadione
and with the AOX blocked is associated with an increased
level of cell ROS.
Our results showed clearly that the inhibition of the
expression of the AOX was associated with intracellular
ROS accumulation, revealing the effect of the ARP on
oxidative damage. Although fluconazole resistance was
unrelated to the presence of the ARP, we can consider
that it confers antifungal tolerance, which may give yeast
cells enough time to develop long-term genetically stable
resistance mechanisms (Cannon et al., 2009).
The ARP is a potential target that should be taken into
account when considering the development of new thera-
peutic strategies in the case of C. krusei infections.
Attending to its selective effect, SHAM should be used in
combination with azoles, to reduce resistance because
of oxidative stress and consequently the virulence of
C. krusei.
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